- Who can participate: Adults aged 18-65 with a confirmed diagnosis of Type 2 Diabetes and not currently on insulin therapy are eligible to participate. Additional criteria include stable blood sugar levels and no history of severe cardiovascular events.
- Study details: Participants will be required to take the investigational medication daily and attend scheduled clinical visits for health assessments, blood tests, and monitoring of blood sugar levels.
The prescreener preview is complete. You may now close the preview.